Matthew A Ingersoll

2PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 14, 2023
Repurposing AZD5438 and Dabrafenib for Cisplatin-Induced AKI.

Chithra K Pushpan, Daniel F Kresock, Matthew A Ingersoll

|Dec 03, 2020
BRAF inhibition protects against hearing loss in mice.

Matthew A Ingersoll, Emma A Malloy, Lauryn E Caster

Pageof 1